Literature DB >> 9382036

Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.

H H Xia1, N J Talley.   

Abstract

OBJECTIVES: The natural history of Helicobacter pylori infection in humans is not well established. We aimed to systematically review the literature on the natural acquisition and spontaneous elimination of the infection and its clinical consequences.
METHODS: A broad-based MEDLINE and Current Contents search was performed to identify all related publications between 1986 and 1996. Abstracts from recent major conferences that provided adequate data were also included.
RESULTS: The prevalence of H. pylori infection increases with age, the rates being significantly lower in developed countries than in developing countries. However, the overall prevalence is decreasing in both developing and developed countries, which probably is responsible for the steep decline of gastric cancer in some industrialized countries. The natural acquisition of H. pylori infection occurs, for the most part, in childhood, and it appears that the incidence is currently slightly higher in developing countries than in industrialized countries. Spontaneous elimination of the infection also occurs, especially in young children and the elderly. The route of transmission continues to be uncertain, with the best evidence favoring both the gastro-oral and fecal-oral routes. Low socioeconomic status is a major risk factor for acquisition of the infection. Genetics probably plays a role in the acquisition or clearance of H. pylori infection in individuals.
CONCLUSIONS: Low rates of natural acquisition and elimination of the infection in adults suggest that it is worthwhile to eradicate the organism from adults, but there should be further evaluation of the need for eradication of H. pylori in children.

Entities:  

Mesh:

Year:  1997        PMID: 9382036

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  43 in total

1.  Vaccines against gut pathogens.

Authors:  P Mastroeni; F Bowe; R Cahill; C Simmons; G Dougan
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

Review 2.  Helicobacter pylori infection transmitted sexually via oral-genital contact: a hypothetical model.

Authors:  G D Eslick
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

3.  Detection of Helicobacter pylori antibodies in pediatric populations.

Authors:  P A Marchildon
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice.

Authors:  F J Radcliff; R L Ferrero
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 5.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 6.  Helicobacter pylori in First Nations and recent immigrant populations in Canada.

Authors:  Nicola Jones; Naoki Chiba; Carlo Fallone; Alan Thompson; Richard Hunt; Kevan Jacobson; Karen Goodman
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

Review 7.  How labile is gastric infection with H pylori?

Authors:  M Hobsley; F-I Tovey; J Holton
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

9.  Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections.

Authors:  Wai-Keung Leung; Lawrence Cheung-Tsui Hung; Carrie Ka-Li Kwok; Rupert Wing-Loong Leong; Daniel Kwok-Keung Ng; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.

Authors:  Jennifer M Yeh; Karen M Kuntz; Majid Ezzati; Sue J Goldie
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.